Reference region extraction by clustering for the pharmacokinetic analysis of dynamic contrast-enhanced MRI in prostate cancer.

PURPOSE Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) measures changes in the concentration of an administered contrast agent to quantitatively evaluate blood circulation in a tumor or normal tissues. This method uses a pharmacokinetic analysis based on the time course of a reference region, such as muscle, rather than arterial input function. However, it is difficult to manually define a homogeneous reference region. In the present study, we developed a method for automatic extraction of the reference region using a clustering algorithm based on a time course pattern for DCE-MRI studies of patients with prostate cancer. METHODS Two feature values related to the shape of the time course were extracted from the time course of all voxels in the DCE-MRI images. Each voxel value of T1-weighted images acquired before administration were also added as anatomical data. Using this three-dimensional feature vector, all voxels were segmented into five clusters by the Gaussian mixture model, and one of these clusters that included the gluteus muscle was selected as the reference region. RESULTS Each region of arterial vessel, muscle, and fat was segmented as a different cluster from the tumor and normal tissues in the prostate. In the extracted reference region, other tissue elements including scattered fat and blood vessels were removed from the muscle region. CONCLUSIONS Our proposed method can automatically extract the reference region using the clustering algorithm with three types of features based on the time course pattern and anatomical data. This method may be useful for evaluating tumor circulatory function in DCE-MRI studies.

[1]  J Kurhanewicz,et al.  Dynamic contrast‐enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI , 2005, Magnetic resonance in medicine.

[2]  D. Dearnaley,et al.  Dynamic contrast-enhanced MRI for prostate cancer localization. , 2009, The British journal of radiology.

[3]  Ivan Yeung,et al.  Comparison of quantitative parameters in cervix cancer measured by dynamic contrast–enhanced MRI and CT , 2010, Magnetic resonance in medicine.

[4]  A. Jackson,et al.  Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.

[5]  A. Oto,et al.  Arterial input functions (AIFs) measured directly from arteries with low and standard doses of contrast agent, and AIFs derived from reference tissues. , 2016, Magnetic resonance imaging.

[6]  Richard Frayne,et al.  The impact of partial‐volume effects in dynamic susceptibility contrast magnetic resonance perfusion imaging , 2005, Journal of magnetic resonance imaging : JMRI.

[7]  Geoff J M Parker,et al.  The effect of blood inflow and B1‐field inhomogeneity on measurement of the arterial input function in axial 3D spoiled gradient echo dynamic contrast‐enhanced MRI , 2011, Magnetic resonance in medicine.

[8]  Steven P Sourbron,et al.  Classic models for dynamic contrast‐enhanced MRI , 2013, NMR in biomedicine.

[9]  Gregory S Karczmar,et al.  Multiple reference tissue method for contrast agent arterial input function estimation , 2007, Magnetic resonance in medicine.

[10]  Guang-Zhong Yang,et al.  Bayesian Methods for Pharmacokinetic Models in Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2006, IEEE Transactions on Medical Imaging.

[11]  Evis Sala,et al.  Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. , 2007, The Lancet. Oncology.

[12]  Henkjan J Huisman,et al.  Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.

[13]  David Atkinson,et al.  Bayesian estimation of pharmacokinetic parameters for DCE-MRI with a robust treatment of enhancement onset time. , 2007, Physics in medicine and biology.

[14]  Joseph S Koopmeiners,et al.  Detection of Prostate Cancer: Quantitative Multiparametric MR Imaging Models Developed Using Registered Correlative Histopathology. , 2016, Radiology.

[15]  J. Gore,et al.  Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. , 2005, Magnetic resonance imaging.

[16]  Alberto Righetti,et al.  Inflow effect in first‐pass cardiac and renal MRI , 2003, Journal of magnetic resonance imaging : JMRI.

[17]  A. Evans,et al.  Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[18]  Yuichi Kimura,et al.  Improved Signal-to-Noise Ratio in Parametric Images by Cluster Analysis , 1999, NeuroImage.

[19]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[20]  Dow-Mu Koh,et al.  Assessment of the effect of haematocrit‐dependent arterial input functions on the accuracy of pharmacokinetic parameters in dynamic contrast‐enhanced MRI , 2011, NMR in biomedicine.

[21]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Interactions Using a Reference Tissue Model and Cluster Analysis , 1998 .

[22]  D J Collins,et al.  Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis , 2006, Physics in medicine and biology.

[23]  F. Turkheimer,et al.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.

[25]  E. Rostrup,et al.  Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging , 1996, Magnetic resonance in medicine.

[26]  David Atkinson,et al.  A comparison of Bayesian and non-linear regression methods for robust estimation of pharmacokinetics in DCE-MRI and how it affects cancer diagnosis , 2017, Comput. Medical Imaging Graph..

[27]  Hai-Ling Margaret Cheng,et al.  T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1‐weighted DCE‐MRI , 2007, Journal of magnetic resonance imaging : JMRI.

[28]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[29]  David Atkinson,et al.  Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI , 2008, Physics in medicine and biology.

[30]  K Wells,et al.  Partial volume effects in dynamic contrast magnetic resonance renal studies. , 2010, European journal of radiology.

[31]  P. Tofts Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[32]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[33]  G S Karczmar,et al.  A new method for imaging perfusion and contrast extraction fraction: Input functions derived from reference tissues , 1998, Journal of magnetic resonance imaging : JMRI.

[34]  Gregory S Karczmar,et al.  Estimating the arterial input function using two reference tissues in dynamic contrast‐enhanced MRI studies: Fundamental concepts and simulations , 2004, Magnetic resonance in medicine.

[35]  Steven P Sourbron,et al.  On the scope and interpretation of the Tofts models for DCE‐MRI , 2011, Magnetic resonance in medicine.

[36]  R. Wirestam,et al.  Effects of inflow and radiofrequency spoiling on the arterial input function in dynamic contrast‐enhanced MRI: A combined phantom and simulation study , 2011, Magnetic resonance in medicine.

[37]  Evis Sala,et al.  Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. , 2009, International journal of radiation oncology, biology, physics.

[38]  L. R. Jensen,et al.  Peripheral Zone Prostate Cancer Localization by Multiparametric Magnetic Resonance at 3 T: Unbiased Cancer Identification by Matching to Histopathology , 2012, Investigative radiology.

[39]  A R Padhani,et al.  Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. , 2001, Clinical radiology.

[40]  Stuart A. Taylor,et al.  Zone-specific logistic regression models improve classification of prostate cancer on multi-parametric MRI , 2015, European Radiology.

[41]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.